Search results
Results from the WOW.Com Content Network
The American Cancer Society reported that women under 65 are getting cancer at higher rates. Breast cancer cases are the most common, but female lung cancer diagnoses are also soaring.
The Summary. A new report shows that cancer cases are shifting from men to women in the United States and from older to younger adults. For the first time, cancer rates in women ages 50 to 64 have ...
The American Cancer Society's annual report says there's also been a gender shift in cancer cases. "Now we see for the first time, if you're a woman under the age of 65, you're now more likely to ...
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
SEER collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 34.6% of the population of the United States. SEER coverage includes 30.0% of African Americans, 44% of Hispanics, 49.3% of American Indians and Alaska Natives, 57.5% of Asians, and 68.5% of Hawaiian/Pacific Islanders. [3]
The American Cancer Society (ACS) is a nationwide non-profit organization dedicated to eliminating cancer. Established in 1913, the society is organized into six geographical regions of both medical and lay volunteers operating in more than 250 Regional offices throughout the United States. [ 1 ]
Women are now being diagnosed with cancer more often than men in certain age groups, according to a new report from the American Cancer Society. Among adults aged 50-64, cancer rates are slightly ...
Small cell lung cancer has a five-year survival rate of 4% according to Cancer Centers of America's Website. [5] The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer.